The US Food and Drug Administration (FDA) has granted Establishment Inspection Report (EIR) to Lupin’s Ankleshwar manufacturing facility, located in Gujarat, according to a statement by Lupin.
The statement informed that the inspection of the facility was conducted from 16th to 19th August, 2022.
Your blog is very informative. thanks for Sharing this blog.